If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. Checkbox not checked

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D




Comment for Type of Reporting Person:
(1) Sole voting and dispositive power includes 414,811 Shares (as defined herein) that the Reporting Person has the right to acquire within 60 days of the date of this filing. (2) Percent of class is calculated based on a total of 146,563,031 Shares outstanding as of May 7, 2025, as reported in the Issuer's quarterly report on Form 10-Q filed with the SEC (as defined herein) on May 13, 2025, plus 414,811 Shares that the Reporting Person has the right to acquire within 60 days of the date of this filing.


SCHEDULE 13D




Comment for Type of Reporting Person:
(1) Percent of class is calculated based on a total of 146,563,031 Shares outstanding as of May 7, 2025, as reported in the Issuer's quarterly report on Form 10-Q filed with the SEC on May 13, 2025.


SCHEDULE 13D




Comment for Type of Reporting Person:
(1) Percent of class is calculated based on a total of 146,563,031 Shares outstanding as of May 7, 2025, as reported in the Issuer's quarterly report on Form 10-Q filed with the SEC on May 13, 2025.


SCHEDULE 13D


 
SCHULER JACK W
 
Signature:/s/ Jack W. Schuler
Name/Title:Jack W. Schuler
Date:05/20/2025
 
Jack W. Schuler Living Trust
 
Signature:/s/ Jack W. Schuler
Name/Title:Jack W. Schuler, Trustee
Date:05/20/2025
 
Jack W. Schuler 2025 GRAT
 
Signature:/s/ Jack W. Schuler
Name/Title:Jack W. Schuler, Trustee
Date:05/20/2025
EXHIBIT 7
 
JOINT FILING AGREEMENT
 
The undersigned hereby agree that the statement on Schedule 13D with respect to the common stock of Biodesix, Inc. dated as of May 20, 2025 is, and any amendments thereto (including amendments on Schedule 13G) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934.
 
 
Jack W. Schuler
 
 
 
 
 
 
/s/ Jack W. Schuler
 
     
     
 
Jack W. Schuler Living Trust
 
 
 
 
 
 
/s/ Jack W. Schuler
 
 
Name: Jack W. Schuler
 
 
Title: Trustee
 
     
     
 
Jack W. Schuler 2025 GRAT
 
 
 
 
 
 
/s/ Jack W. Schuler
 
 
Name: Jack W. Schuler
 
 
Title: Trustee
 



May 20, 2025